172 related articles for article (PubMed ID: 20133464)
1. Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3.
Nesbit MA; Hannan FM; Graham U; Whyte MP; Morrison PJ; Hunter SJ; Thakker RV
J Clin Endocrinol Metab; 2010 Apr; 95(4):1947-54. PubMed ID: 20133464
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3.
Hannan FM; Nesbit MA; Turner JJ; Stacey JM; Cianferotti L; Christie PT; Conigrave AD; Whyte MP; Thakker RV
Eur J Hum Genet; 2010 Apr; 18(4):442-7. PubMed ID: 19809483
[TBL] [Abstract][Full Text] [Related]
3. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.
Hendy GN; Canaff L; Newfield RS; Tripto-Shkolnik L; Wong BY; Lee BS; Cole DE
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1311-5. PubMed ID: 24731014
[TBL] [Abstract][Full Text] [Related]
4. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.
Lloyd SE; Pannett AA; Dixon PH; Whyte MP; Thakker RV
Am J Hum Genet; 1999 Jan; 64(1):189-95. PubMed ID: 9915958
[TBL] [Abstract][Full Text] [Related]
5. A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).
Gorvin CM; Cranston T; Hannan FM; Rust N; Qureshi A; Nesbit MA; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1200-6. PubMed ID: 26729423
[TBL] [Abstract][Full Text] [Related]
6. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
[TBL] [Abstract][Full Text] [Related]
7. Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects.
Hannan FM; Howles SA; Rogers A; Cranston T; Gorvin CM; Babinsky VN; Reed AA; Thakker CE; Bockenhauer D; Brown RS; Connell JM; Cook J; Darzy K; Ehtisham S; Graham U; Hulse T; Hunter SJ; Izatt L; Kumar D; McKenna MJ; McKnight JA; Morrison PJ; Mughal MZ; O'Halloran D; Pearce SH; Porteous ME; Rahman M; Richardson T; Robinson R; Scheers I; Siddique H; Van't Hoff WG; Wang T; Whyte MP; Nesbit MA; Thakker RV
Hum Mol Genet; 2015 Sep; 24(18):5079-92. PubMed ID: 26082470
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).
Dharmaraj P; Gorvin CM; Soni A; Nelhans ND; Olesen MK; Boon H; Cranston T; Thakker RV; Hannan FM
J Clin Endocrinol Metab; 2020 May; 105(5):1393-400. PubMed ID: 32150253
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
[TBL] [Abstract][Full Text] [Related]
10. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
Mahajan A; Buse J; Kline G
Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
[TBL] [Abstract][Full Text] [Related]
12. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
14. A Hong Kong Chinese kindred with familial hypocalciuric hypercalcaemia caused by
Wong FCK; Wong WS; Kwok JSS; Tsui TKC; Lau KP; Chan MHM; Yuen YP
F1000Res; 2019; 8():1612. PubMed ID: 31723423
[TBL] [Abstract][Full Text] [Related]
15. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
[TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
17. Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia.
Lam CW; Lee KF; Chan AO; Poon PM; Law TY; Tong SF
Clin Chim Acta; 2005 Oct; 360(1-2):167-72. PubMed ID: 15963484
[TBL] [Abstract][Full Text] [Related]
18. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
[TBL] [Abstract][Full Text] [Related]
20. [Familial hypocalciuric hypercalcemia: a new mutation].
Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]